Provided by Tiger Trade Technology Pte. Ltd.

Bio-Techne

72.32
+0.04000.06%
Post-market: 72.320.00000.00%19:30 EDT
Volume:3.96M
Turnover:286.20M
Market Cap:11.27B
PE:62.34
High:72.35
Open:72.32
Low:72.27
Close:72.28
52wk High:72.62
52wk Low:43.20
Shares:155.81M
Float Shares:155.81M
Volume Ratio:1.46
T/O Rate:2.54%
Dividend:0.32
Dividend Rate:0.44%
EPS(TTM):1.16
EPS(LYR):1.16
ROE:9.03%
ROA:6.26%
PB:5.34
PE(LYR):62.34

Loading ...

Exchange-Traded Funds, Equity Futures Higher Pre-Bell Thursday as Investors Embrace AI Growth Themes, Reduced Middle East Risks

MT Newswires Live
·
Jun 25

Merck Kgaa Exec Says Bio-techne Deal Expected to Have One-time Costs of About 500 Million Euros- Conf Call

THOMSON REUTERS
·
Jun 25

Baird Adjusts Price Target on Bio-Techne to $73 From $49, Maintains Neutral Rating

MT Newswires Live
·
Jun 25

US Stocks-nasdaq Futures Surge 2% as Chip Outlook Calms AI Jitters; Inflation Data Awaited

Reuters
·
Jun 25

S&P 500 Futures Climb in Premarket Trading; Bio-techne, Micron Technology Lead

Dow Jones
·
Jun 25

Here are Five Themes Wall Street Left Behind While Chasing a Single Trade

Dow Jones
·
Jun 25

Dow Jones Top Company Headlines at 7 am ET: Germany's Merck to Buy Bio-techne for $11 Billion | Anthropic ...

Dow Jones
·
Jun 25

Alerts Incorrectly Tagged to Merck & Co Withdrawn

Reuters
·
Jun 25

Major Deals Involving US Drugmakers and Biotechs over the Past Decade

Reuters
·
Jun 25

Germany's Merck Boosts Life Sciences Business with $11 Billion Bet on Bio-techne

Reuters
·
Jun 25

Bio-techne Corp - Deal Valued at $11.3 Bln, $73 Per Share in Cash

THOMSON REUTERS
·
Jun 25

Bio-techne Corp - Expects Annual Cost Synergies of EUR 140 Mln by Year 3 After Closing

THOMSON REUTERS
·
Jun 25

Bio-techne Corp - Acquisition Expected to be Immediately Accretive to Sales Growth and Ebitda Pre Margin

THOMSON REUTERS
·
Jun 25

Merck Kgaa, Darmstadt, Germany, Agrees to Acquire Bio-techne, Strengthening Leadership Position in Fast-growing Life Sciences Markets

THOMSON REUTERS
·
Jun 25

Bio-techne Corp Shares up 25.3% Premarket on Merck Kgaa's $11.3 Billion Buyout Deal

THOMSON REUTERS
·
Jun 25

Merck Agrees to Buy Bio-techne for USD 73 Per Share in Cash, Valuing Deal at USD 11.3 Billion

Reuters
·
Jun 25

US stocks climb even as Apple price hikes offset chipmaker strength

Geoffrey Morgan & Jackie Edwards / Bloomberg
·
Jun 25

Movement Alert|Bio-Techne Rises 5.57% in Regular Trading, Trading at $59.45

Market Focus
·
Jun 25

Analyst Reiterates Buy on Bio-Techne, Sees Undervalued Shares and Margin Upside with Unchanged $65 Price Target

TIPRANKS
·
Jun 23

Bio-Techne Corp. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
Jun 23